Maximising efficacy in HER2-positive breast cancer: immunoliposomal co-delivery of miR155 inhibitor and paclitaxel for targeted therapy
Year: 2024
Type: article
Source: Journal of Materials Chemistry B
DOI: 10.1039/d4tb01090f
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
Award: G4148978689
OpenAlex ID: W4404956717
